IVF with gender selection in Thailand typically costs between AUD $18,985 / ฿A645,505 and AUD $29,916 / ฿A1,017,159. Prices fluctuate based on the specific genetic screening technology used and the required hormone medication dosage. Patients from Australia save approximately 12% compared to local prices, which average AUD $21,574 / ฿A733,528. Standard cycles generally include egg retrieval, laboratory fertilisation, genetic testing for gender balancing, and the first embryo transfer.
Bookimed Expert Insight: Australian patients frequently choose Bangkok for its high concentration of accredited specialists. Prime Fertility Clinic, for example, is one of the few standalone centres globally with JCI ambulatory care accreditation. This reflects a commitment to safety that matches Australian private standards. Specialists like Dr. Teraporn Vutyavanich use advanced protocols that help justify the investment in travel for complex family balancing cases.
| Thailand | Turkey | South Korea | |
| IVF with Gender Selection | from AUD $19,053 / ฿A647,803 | from AUD $9,349 / ฿A317,862 | from AUD $14,671 / ฿A498,799 |
Dr. Wasin Naknam is an obstetrician-gynecologist and reproductive medicine specialist. He earned his MD from Chiang Mai University, Thailand, in 2012. He received Thai Board certification in Obstetrics and Gynecology in 2016. He completed the Thai Board of Infertility and Assisted Reproductive Technology in 2018. He obtained a master’s in Biotechnology of Assisted Human Reproduction and Embryology from the University of Valencia, Spain, in 2021.
Clinical focus: IUI and IVF/ICSI (long, antagonist, and double stimulation protocols). Customized ovarian stimulation for poor ovarian reserve and PCOS. Targeted care for repeated embryo transfer failure. PGT-A, PGT-M, and PGT-SR. Laparoscopy and hysteroscopy for infertility.
Professional activities: ESHRE workshops and annual meetings in 2017 (Geneva), 2018 (Barcelona), and 2019 (Vienna). TSRM seminar and conference in Pattaya in 2019. Poster presentation at ESHRE 2020 (virtual). Memberships: ASPIRE, ESHRE, ASRM, and TSRM.
Dr. Chaisuk Jiwatanaporn is an obstetrician-gynaecologist (OB-GYN) with a subspecialty in reproductive medicine. Dr. Jiwatanaporn earned an MD from the Faculty of Medicine, Chulalongkorn University in 1999. Dr. Jiwatanaporn holds the Thai Board in Obstetrics and Gynaecology from the Medical Council of Thailand, completed at Chonburi Hospital. Dr. Jiwatanaporn completed a fellowship in reproductive medicine at Chulalongkorn University in 2009. Practice areas include general obstetrics and gynaecology, reproductive endocrinology and infertility, and gynaecologic endoscopy.
Continuing education includes ESHRE workshops and annual meetings in Lisbon (2016), Geneva (2017), Barcelona (2018), and Vienna (2019). Additional meetings include ASPIRE 2019 in Hong Kong, TSRM 2019 in Pattaya, and COGI 2019 in Paris. Professional memberships include the Medical Council of Thailand, RTCOG, TSRM, TSGR, and ESHRE.
Prof. Dr. Teraporn Vutyavanich specializes in Obstetrics & Gynecology, Assisted Reproductive Medicine, and Endocrinology. He is known as the father of assisted reproductive medicine in Thailand and the country’s first specialist in this field. He has authored over 100 publications. He chaired the Thai Society for Reproductive Medicine from 2005 to 2010 and from 2015 to the present.
He is a Professor at Chiang Mai University. He also serves as Director of the Reproductive Center at Chiang Mai University and Medical Director of the Chiang Mai IVF Polyclinic. He holds an MD (Honours) from Mahidol University. He is board-certified by the Thai Board of Obstetrics & Gynaecology and the Thai Subspecialty Board of Reproductive Medicine. He earned an M.Sc. in Medical Sciences from the University of Nottingham and an M.Sc. in research design from McMaster University. He completed fellowships in reproductive endocrinology at New York Hospital–Cornell and the Mayo Clinic under the Ananda Mahidol Scholarship. He is an ESHRE-certified senior embryologist.
Dr. Pitch Chandeying is an OB-GYN with a subspecialty in reproductive medicine. He completed a fellowship in reproductive medicine at the Faculty of Medicine, Chiang Mai University.
He completed certified training in assisted reproductive technology through ATE and TSRM in 2024 and 2025. He also trained in minimally invasive surgery at Siriraj Hospital in 2024.
His expertise includes IUI and IVF/ICSI. He manages complex infertility, such as poor ovarian reserve, PCOS, and recurrent implantation failure. He also performs sperm retrieval for azoospermia (PESA, TESE) and offers PGT-A, PGT-M, and PGT-SR.
He is a member of ESHRE, ASRM, TSRM, and the Association of Thai Embryologists (ATE).
Gender selection for non-medical reasons is legal in Thailand. Patients must meet specific clinic criteria and follow local regulations. Medical centres in Bangkok offer elective sex selection using Preimplantation Genetic Testing (PGT) alongside IVF or ICSI. These options are generally restricted in Australia.
Bookimed Expert Insight: Elective selection is available. The best outcomes happen at high-volume centres like Prime Fertility Clinic, which serves 4,000+ patients annually. These JCI-accredited facilities often include couple diagnostics and endocrinologist consultations in their packages. This helps achieve high embryo transfer success rates.
Patient Consensus: Australians often choose Thailand for elective options and non-medical sex selection unavailable back home. Many note that high embryo transfer success rates and clear communication about genetic testing make the travel worthwhile.
Single individuals and unmarried couples cannot access IVF services in Thailand due to the ART Act. Thai law mandates that patients undergoing invasive fertility treatments must be legally married. Clinics require a certified marriage certificate and passport identification to begin any medical protocols.
Bookimed Expert Insight: While IVF requires marriage, clinics like Prime Fertility Center serve Australian patients with specialised diagnostics. Many centres maintain dual JCI and ISO certifications. This ensures that legally eligible couples receive care identical to major private hospitals in Melbourne or Sydney.
Patient Consensus: Verify eligibility directly with the chosen clinic before booking flights. Ask for a written policy on documentation and whether telehealth pre-assessment is available for international patients in Thailand.
Commercial surrogacy is strictly illegal for Australians in Thailand. These services are prohibited for foreigners under the Protection for Children Born through Assisted Reproductive Technologies Act. Medical gender selection via PGT-A is permitted only during standard IVF for legally married couples.
Bookimed Expert Insight: While surrogacy is restricted, Thailand remains a hub for IVF and genetic testing. Clinics like Deep & Harmonicare IVF Center operate three independent genetic labs for PGT-A and PGT-M. This infrastructure supports high success rates for medical gender selection within standard IVF. Surrogacy is a distinct legal risk handled by separate authorities.
Patient Consensus: Patients note that IVF and surrogacy follow different legal frameworks in Thailand. They suggest arranging legal advice in Australia before starting any international fertility treatment.
Typical IVF success rates in Thailand range from 40% to 65% per cycle. Outcomes mirror global standards in Australia and the United States. Maternal age remains the primary factor. Younger patients under 35 often see success rates between 45% and 60% per fresh embryo transfer.
Bookimed Expert Insight: Thai clinics like Prime Fertility Clinic specifically cater to Australian patients. They hold JCI Ambulatory Care Accreditation. This regulation helps laboratory standards match Australian expectations. High-volume centres perform thousands of cycles annually. This experience often leads to more refined embryo culture techniques.
Patient Consensus: Success rates vary by age and egg quality in Thailand. Clinics offer different metrics like live birth or pregnancy rates. Patients recommend asking for personalised stats based on specific medical history. Pre-implantation genetic testing helps select the healthiest embryos for transfer.
Australian patients usually stay in Thailand for 15 to 21 days for a full IVF cycle. This covers ovarian stimulation, egg retrieval, and embryo transfer. Stays can be 10 to 12 days if stimulation starts in Australia under shared care.
Bookimed Expert Insight: While many clinics offer fresh transfers, LRC Fertility Clinic reports a 79.2% success rate with frozen embryo transfers. Choosing FET allows patients to split the process into two shorter trips. This often reduces travel stress during the implantation window.
Patient Consensus: Plan for one extended holiday or two separate trips. Scheduling extra days for monitoring helps manage protocol changes. Confirming telehealth follow-up before flying home helps with post-travel care.
Fertility clinics in Thailand use Next-Generation Sequencing (NGS) to analyse embryonic DNA for chromosomal issues and genetic disorders. These centres use laser-assisted biopsies and time-lapse imaging to monitor growth. Specialists like Dr Wasin Naknam at Deep and Harmonicare IVF Center use these tools to select viable embryos for transfer.
Bookimed Expert Insight: Thai centres like Deep and Harmonicare IVF Center operate three independent genetic labs. This setup means PGT-A for chromosomal status and PGT-SR for structural issues occur in specialised environments. This infrastructure helps Thailand maintain a high global rank for assisted reproduction services.
Patient Consensus: Patients in Thailand note that genetic testing is a distinct laboratory stage usually involving embryo biopsy. Confirming which specific PGT method is included in the IVF package helps manage budget and expectations.